These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4056842)

  • 1. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index.
    Boccadoro M; Gallamini A; Fruttero A; Gavarotti P; Redoglia V; Buffa F; Ruá S; Pileri A
    J Clin Oncol; 1985 Nov; 3(11):1503-7. PubMed ID: 4056842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
    Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
    Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
    Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
    J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between plasma cell thymidine labelling index and serum beta-2-microglobulin in monoclonal gammopathies.
    Boccadoro M; Durie BG; Frutiger Y; Gavarotti P; Redoglia V; Massaia M; D'Alberto M; Marmont F; Gallamini A; Tribalto M
    Acta Haematol; 1987; 78(4):239-42. PubMed ID: 3122489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytobiological studies in multiple myeloma.
    Pileri A; Massaia M; Dianzani U; Omedè P; Boccadoro M
    Acta Haematol; 1987; 78 Suppl 1():41-2. PubMed ID: 2829488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of leucocyte alkaline phosphatase (LAP) score in differentiating malignant from benign paraproteinaemias.
    Majumdar G; Hunt M; Singh AK
    J Clin Pathol; 1991 Jul; 44(7):606-7. PubMed ID: 1713223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.
    Girino M; Riccardi A; Luoni R; Ucci G; Cuomo A
    Acta Haematol; 1991; 85(1):26-30. PubMed ID: 2011926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of aldehyde dehydrogenase in B-cell and plasma cell subsets of monoclonal gammopathy patients and healthy donors.
    Všianská P; Bezděková R; Kryukov F; Almáši M; Pour L; Penka M; Hájek R; Říhová L
    Eur J Haematol; 2017 Jan; 98(1):19-25. PubMed ID: 27199264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialyltransferase activity and sialic acid levels in multiple myeloma and monoclonal gammopathy.
    Cohen AM; Allalouf D; Bessler H; Djaldetti M; Malachi T; Levinsky H
    Eur J Haematol; 1989 Mar; 42(3):289-92. PubMed ID: 2924892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in plasma cell dyscrasias.
    Xu D; Zheng C; Bergenbrant S; Holm G; Björkholm M; Yi Q; Gruber A
    Br J Cancer; 2001 Mar; 84(5):621-5. PubMed ID: 11237381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies.
    Witzig TE; Gonchoroff NJ; Katzmann JA; Therneau TM; Kyle RA; Greipp PR
    J Clin Oncol; 1988 Jun; 6(6):1041-6. PubMed ID: 3286829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study.
    Saeed SM; Stock-Novack D; Pohlod R; Crowley J; Salmon SE
    Blood; 1991 Dec; 78(12):3281-7. PubMed ID: 1742488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased ecto-5'nucleotidase activity of peripheral blood lymphocytes in human monoclonal gammopathies: correlation with tumor cell kinetics.
    Massaia M; Ma DD; Boccadoro M; Golzio F; Gavarotti P; Dianzani U; Pileri A
    Blood; 1985 Mar; 65(3):530-4. PubMed ID: 2982438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
    Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
    Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies.
    Greipp PR; Witzig TE; Gonchoroff NJ; Habermann TM; Katzmann JA; O'Fallon WM; Kyle RA
    Mayo Clin Proc; 1987 Nov; 62(11):969-77. PubMed ID: 3118117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Milanesi B; Tafuri C; Perini M; Rota G; Peretti P
    Quad Sclavo Diagn; 1984 Jun; 20(2):149-54. PubMed ID: 6528014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte alkaline phosphatase score in plasma cell dyscrasias: correlation with disease severity and circulating levels of granulocyte-colony stimulating factor.
    Stasi R; Bruno A; Venditti A; Del Poeta G; Coppetelli U; Tribalto M; Papa G
    Leuk Lymphoma; 1995 May; 17(5-6):479-83. PubMed ID: 7549841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.